Clinical Trials Browser

Phase 2/3 × Carcinoma, Non-Small-Cell Lung × CTLA-4 Antigen × Clear all

NCT04929041 2026-03-19

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

Phase 2/3 Suspended

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms